Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Computed Diffusion-Weighted Imaging in Prostate Cancer: Basics, Advantages, Cautions, and Future Prospects

  • Ueno, Yoshiko R. (Department of Radiology, Kobe University Graduate School of Medicine) ;
  • Tamada, Tsutomu (Department of Radiology, Kawasaki Medical School) ;
  • Takahashi, Satoru (Department of Radiology, Kobe University Graduate School of Medicine) ;
  • Tanaka, Utaru (Department of Radiology, Kobe University Graduate School of Medicine) ;
  • Sofue, Keitaro (Department of Radiology, Kobe University Graduate School of Medicine) ;
  • Kanda, Tomonori (Department of Radiology, Kobe University Graduate School of Medicine) ;
  • Nogami, Munenobu (Department of Radiology, Kobe University Graduate School of Medicine) ;
  • Ohno, Yoshiharu (Department of Radiology, Kobe University Graduate School of Medicine) ;
  • Hinata, Nobuyuki (Department of Urology, Kobe University Graduate School of Medicine) ;
  • Fujisawa, Masato (Department of Urology, Kobe University Graduate School of Medicine) ;
  • Murakami, Takamichi (Department of Radiology, Kobe University Graduate School of Medicine)
  • Received : 2018.05.08
  • Accepted : 2018.06.20
  • Published : 2018.10.01
⟨ Previous Next ⟩

Abstract

Computed diffusion-weighted MRI is a recently proposed post-processing technique that produces b-value images from diffusion-weighted imaging (DWI), acquired using at least two different b-values. This article presents an argument for computed DWI for prostate cancer by viewing four aspects of DWI: fundamentals, image quality and diagnostic performance, computing procedures, and future uses.

Keywords

References

  1. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622-1635 https://doi.org/10.2214/AJR.06.1403
  2. Kim CK, Park SY, Park JJ, Park BK. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer. AJR Am J Roentgenol 2014;202:W270-W276 https://doi.org/10.2214/AJR.13.11333
  3. Chong Y, Kim CK, Park SY, Park BK, Kwon GY, Park JJ. Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. AJR Am J Roentgenol 2014;202:772-777 https://doi.org/10.2214/AJR.13.11187
  4. Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011;261:46-66 https://doi.org/10.1148/radiol.11091822
  5. Tamada T, Sone T, Jo Y, Yamamoto A, Ito K. Diffusionweighted MRI and its role in prostate cancer. NMR Biomed 2014;27:25-38 https://doi.org/10.1002/nbm.2956
  6. Metens T, Miranda D, Absil J, Matos C. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 2012;22:703-709 https://doi.org/10.1007/s00330-011-2298-9
  7. Katahira K, Takahara T, Kwee TC, Oda S, Suzuki Y, Morishita S, et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 2011;21:188-196 https://doi.org/10.1007/s00330-010-1883-7
  8. Ueno Y, Kitajima K, Sugimura K, Kawakami F, Miyake H, Obara M, et al. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI. J Magn Reson Imaging 2013;38:154-160 https://doi.org/10.1002/jmri.23953
  9. Tamada T, Kanomata N, Sone T, Jo Y, Miyaji Y, Higashi H, et al. High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness. PLoS One 2014;9:e96619 https://doi.org/10.1371/journal.pone.0096619
  10. Koh DM, Blackledge M, Padhani AR, Takahara T, Kwee TC, Leach MO, et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 2012;199:252-262 https://doi.org/10.2214/AJR.11.7866
  11. Blackledge MD, Leach MO, Collins DJ, Koh DM. Computed diffusion-weighted MR imaging may improve tumor detection. Radiology 2011;261:573-581 https://doi.org/10.1148/radiol.11101919
  12. Rohde GK, Barnett AS, Basser PJ, Marenco S, Pierpaoli C. Comprehensive approach for correction of motion and distortion in diffusion-weighted MRI. Magn Reson Med 2004;51:103-114 https://doi.org/10.1002/mrm.10677
  13. Rosenkrantz AB, Chandarana H, Hindman N, Deng FM, Babb JS, Taneja SS, et al. Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection. Eur Radiol 2013;23:3170-3177 https://doi.org/10.1007/s00330-013-2917-8
  14. Bammer R, Keeling SL, Augustin M, Pruessmann KP, Wolf R, Stollberger R, et al. Improved diffusion-weighted singleshot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med 2001;46:548-554 https://doi.org/10.1002/mrm.1226
  15. Zhu Y. Parallel excitation with an array of transmit coils. Magn Reson Med 2004;51:775-784 https://doi.org/10.1002/mrm.20011
  16. Maas MC, Futterer JJ, Scheenen TW. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate. Invest Radiol 2013;48:779-786 https://doi.org/10.1097/RLI.0b013e31829705bb
  17. Ueno Y, Takahashi S, Kitajima K, Kimura T, Aoki I, Kawakami F, et al. Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis. Eur Radiol 2013;23:3509-3516 https://doi.org/10.1007/s00330-013-2958-z
  18. Yoshida R, Yoshizako T, Katsube T, Tamaki Y, Ishikawa N, Kitagaki H. Computed diffusion-weighted imaging using 1.5-T magnetic resonance imaging for prostate cancer diagnosis. Clin Imaging 2017;41:78-82 https://doi.org/10.1016/j.clinimag.2016.10.005
  19. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. Radiology 2009;250:145-151 https://doi.org/10.1148/radiol.2501080207
  20. Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, et al. Combined T2-weighted and diffusionweighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007;189:323-328 https://doi.org/10.2214/AJR.07.2211
  21. Kim CK, Park BK, Kim B. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 2010;194:W33-W37 https://doi.org/10.2214/AJR.09.3004
  22. Kwon MR, Kim CK, Kim JH. PI-RADS version 2: evaluation of diffusion-weighted imaging interpretation between b = 1000 and b = 1500 s mm-2. Br J Radiol 2017;90:20170438 https://doi.org/10.1259/bjr.20170438
  23. Koo JH, Kim CK, Choi D, Park BK, Kwon GY, Kim B. Diffusionweighted magnetic resonance imaging for the evaluation of prostate cancer: optimal B value at 3T. Korean J Radiol 2013;14:61-69 https://doi.org/10.3348/kjr.2013.14.1.61
  24. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging - Reporting and data system: 2015, Version 2. Eur Urol 2016;69:16-40 https://doi.org/10.1016/j.eururo.2015.08.052
  25. Vargas HA, Hotker AM, Goldman DA, Moskowitz CS, Gondo T, Matsumoto K, et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 2016;26:1606-1612 https://doi.org/10.1007/s00330-015-4015-6
  26. Ueno Y, Takahashi S, Ohno Y, Kitajima K, Yui M, Kassai Y, et al. Computed diffusion-weighted MRI for prostate cancer detection: the influence of the combinations of b-values. Br J Radiol 2015;88:20140738 https://doi.org/10.1259/bjr.20140738
  27. Koh DM, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 2011;196:1351-1361 https://doi.org/10.2214/AJR.10.5515
  28. Ogura A, Koyama D, Hayashi N, Hatano I, Osakabe K, Yamaguchi N. Optimal b values for generation of computed high-b-value DW images. AJR Am J Roentgenol 2016;206:713-718 https://doi.org/10.2214/AJR.15.14867
  29. Rosenkrantz AB, Parikh N, Kierans AS, Kong MX, Babb JS, Taneja SS, et al. Prostate cancer detection using computed very high b-value diffusion-weighted imaging: how high should we go? Acad Radiol 2016;23:704-711 https://doi.org/10.1016/j.acra.2016.02.003
  30. Kimura T, Machii Y. Computed diffusion weighted imaging under Rician noise distribution. Abstract 3574. International Society for Magnetic Resonance in Medicine. Proceedings of the International Society for Magnetic Resonance in Medicine; May 4-11, 2012; Melbourne, AU
  31. Verma S, Sarkar S, Young J, Venkataraman R, Yang X, Bhavsar A, et al. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection. Abdom Radiol (NY) 2016;41:934-945 https://doi.org/10.1007/s00261-015-0619-1
  32. Medved M, Soylu-Boy FN, Karademir I, Sethi I, Yousuf A, Karczmar GS, et al. High-resolution diffusion-weighted imaging of the prostate. AJR Am J Roentgenol 2014;203:85-90 https://doi.org/10.2214/AJR.13.11098
  33. Hwang J, Hong SS, Kim HJ, Chang YW, Nam BD, Oh E, et al. Reduced field-of-view diffusion-weighted MRI in patients with cervical cancer. Br J Radiol 2018;91:20170864
  34. Bittencourt LK, Attenberger UI, Lima D, Strecker R, de Oliveira A, Schoenberg SO, et al. Feasibility study of computed vs measured high b-value (1400 s/mm2) diffusion-weighted MR images of the prostate. World J Radiol 2014;6:374-380 https://doi.org/10.4329/wjr.v6.i6.374
  35. Ueno Y, Takahashi S, Ohno Y, Kyotani K, Yui M, kassai Y, et al. High-resolution computed DWI with high b-value: a preliminary study for improving prostate cancer detection at 3T MR system. Abstract 1540. International Society for Magnetic Resonance in Medicine. Proceedings of the International Society for Magnetic Resonance in Medicine; May 30-June 5, 2015; Toronto, ON, Canada
  36. Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011;259:453-461 https://doi.org/10.1148/radiol.11091409
  37. Waseda Y, Yoshida S, Takahara T, Kwee TC, Matsuoka Y, Saito K, et al. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer. J Magn Reson Imaging 2017;46:490-496 https://doi.org/10.1002/jmri.25593

Cited by

  1. Why Is a b-value Range of 1500-2000 s/mm2 Optimal for Evaluating Prostatic Index Lesions on Synthetic Diffusion-Weighted Imaging? vol.22, pp.6, 2018, https://doi.org/10.3348/kjr.2020.0836
  2. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis vol.46, pp.2, 2021, https://doi.org/10.1007/s00261-020-02695-0
  3. Diagnostic Benefit of High b-Value Computed Diffusion-Weighted Imaging in Patients with Hepatic Metastasis vol.10, pp.22, 2021, https://doi.org/10.3390/jcm10225289
  4. The role of MRI in comparison between benign and malignant chest wall masses in correlation with pathology vol.52, pp.1, 2018, https://doi.org/10.1186/s43055-021-00449-6